FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890146673> ?p ?o ?g. }

• W2890146673 endingPage "e000289" @default.
• W2890146673 startingPage "e000289" @default.
• W2890146673 abstract "Despite extensive multidisciplinary team (MDT) assessment, some patients have interstitial lung disease (ILD) that is considered unclassifiable (uILD), for which there are currently no approved treatments. This study will assess the efficacy and safety of the antifibrotic pirfenidone in treating uILD.This double-blind, randomised, placebo-controlled phase II trial is enrolling adults with fibrosing ILD, including uILD that fulfils proposed research criteria for interstitial pneumonia with autoimmune features (IPAF), that cannot be classified with moderate or high confidence to any category of ILD following MDT discussion. Study participants must have >10% fibrosis on high-resolution CT scan within the previous 12 months, forced vital capacity (FVC) ≥45% and diffusing capacity of the lung for carbon monoxide ≥30% of predicted values. Study participants will be randomised to receive 801 mg pirfenidone or placebo three times daily for 24 weeks. The efficacy of pirfenidone vs placebo will be assessed by daily measurement of FVC using a handheld spirometer over the treatment period. Other functional parameters, patient-reported outcomes, samples for biomarker analysis and safety endpoints will be collected. Additionally, the study will assess the efficacy and safety of pirfenidone with and without concomitant mycophenolate mofetil treatment and in study participants with or without IPAF.This trial is being conducted in accordance with the International Conference on Harmonisation E6 guideline for Good Clinical Practice, Declaration of Helsinki and local laws for countries in which the research is conducted.NCT03099187." @default.
• W2890146673 created "2018-09-27" @default.
• W2890146673 creator A5006969715 @default.
• W2890146673 creator A5014703126 @default.
• W2890146673 creator A5031034216 @default.
• W2890146673 creator A5038098413 @default.
• W2890146673 creator A5045956987 @default.
• W2890146673 creator A5046825438 @default.
• W2890146673 creator A5050993312 @default.
• W2890146673 creator A5055981872 @default.
• W2890146673 creator A5058325633 @default.
• W2890146673 date "2018-09-01" @default.
• W2890146673 modified "2023-10-18" @default.
• W2890146673 title "Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: design of a double-blind, randomised, placebo-controlled phase II trial" @default.
• W2890146673 cites W1665076041 @default.
• W2890146673 cites W1857071204 @default.
• W2890146673 cites W1857313506 @default.
• W2890146673 cites W1966466614 @default.
• W2890146673 cites W1972197732 @default.
• W2890146673 cites W1979209470 @default.
• W2890146673 cites W1993908479 @default.
• W2890146673 cites W1995505342 @default.
• W2890146673 cites W2006604595 @default.
• W2890146673 cites W2010503456 @default.
• W2890146673 cites W2042305090 @default.
• W2890146673 cites W2057292199 @default.
• W2890146673 cites W2077096869 @default.
• W2890146673 cites W2096828977 @default.
• W2890146673 cites W2109734911 @default.
• W2890146673 cites W2118490882 @default.
• W2890146673 cites W2138871107 @default.
• W2890146673 cites W2149661971 @default.
• W2890146673 cites W2157572334 @default.
• W2890146673 cites W2160639837 @default.
• W2890146673 cites W2164264453 @default.
• W2890146673 cites W2168666423 @default.
• W2890146673 cites W2174486202 @default.
• W2890146673 cites W2208096782 @default.
• W2890146673 cites W2336917368 @default.
• W2890146673 cites W2340054689 @default.
• W2890146673 cites W2346218824 @default.
• W2890146673 cites W2346999058 @default.
• W2890146673 cites W2361358989 @default.
• W2890146673 cites W2416914730 @default.
• W2890146673 cites W2440054067 @default.
• W2890146673 cites W2472891063 @default.
• W2890146673 cites W2498506084 @default.
• W2890146673 cites W2513275059 @default.
• W2890146673 cites W2546959556 @default.
• W2890146673 cites W2550171723 @default.
• W2890146673 cites W2558303123 @default.
• W2890146673 cites W2606007227 @default.
• W2890146673 cites W2725698223 @default.
• W2890146673 cites W2755069867 @default.
• W2890146673 doi "https://doi.org/10.1136/bmjresp-2018-000289" @default.
• W2890146673 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6135451" @default.
• W2890146673 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30233802" @default.
• W2890146673 hasPublicationYear "2018" @default.
• W2890146673 type Work @default.
• W2890146673 sameAs 2890146673 @default.
• W2890146673 citedByCount "47" @default.
• W2890146673 countsByYear W28901466732018 @default.
• W2890146673 countsByYear W28901466732019 @default.
• W2890146673 countsByYear W28901466732020 @default.
• W2890146673 countsByYear W28901466732021 @default.
• W2890146673 countsByYear W28901466732022 @default.
• W2890146673 countsByYear W28901466732023 @default.
• W2890146673 crossrefType "journal-article" @default.
• W2890146673 hasAuthorship W2890146673A5006969715 @default.
• W2890146673 hasAuthorship W2890146673A5014703126 @default.
• W2890146673 hasAuthorship W2890146673A5031034216 @default.
• W2890146673 hasAuthorship W2890146673A5038098413 @default.
• W2890146673 hasAuthorship W2890146673A5045956987 @default.
• W2890146673 hasAuthorship W2890146673A5046825438 @default.
• W2890146673 hasAuthorship W2890146673A5050993312 @default.
• W2890146673 hasAuthorship W2890146673A5055981872 @default.
• W2890146673 hasAuthorship W2890146673A5058325633 @default.
• W2890146673 hasBestOaLocation W28901466731 @default.
• W2890146673 hasConcept C126322002 @default.
• W2890146673 hasConcept C141071460 @default.
• W2890146673 hasConcept C142724271 @default.
• W2890146673 hasConcept C1862650 @default.
• W2890146673 hasConcept C203092338 @default.
• W2890146673 hasConcept C204787440 @default.
• W2890146673 hasConcept C27081682 @default.
• W2890146673 hasConcept C2777405647 @default.
• W2890146673 hasConcept C2777543607 @default.
• W2890146673 hasConcept C2777714996 @default.
• W2890146673 hasConcept C2778341716 @default.
• W2890146673 hasConcept C2779832356 @default.
• W2890146673 hasConcept C2780182762 @default.
• W2890146673 hasConcept C2781448352 @default.
• W2890146673 hasConcept C2911091166 @default.
• W2890146673 hasConcept C535046627 @default.
• W2890146673 hasConcept C71924100 @default.
• W2890146673 hasConceptScore W2890146673C126322002 @default.
• W2890146673 hasConceptScore W2890146673C141071460 @default.
• W2890146673 hasConceptScore W2890146673C142724271 @default.

• next